SCHEMBL16438643

SCHEMBL16438643

O=C(O)Nc1ccc(Cl)cc1-c1cccc(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.52
CHRM3 P20309 3/20 0.50
FABP5 Q01469 1/20 0.50
SERPINE1 P05121 3/20 0.48
KDM4E B2RXH2 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
CNR1 P21554 6/20 0.45
FABP3 P05413 1/20 0.45
CHRM1 P11229 2/20 0.44
DHODH Q02127 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CHRM2 P08172 1/20 0.44
AKR1C4 P17516 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
AKR1C1 Q04828 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17796963 0.90 FABP4 (0.62) FABP4CHRM3FABP5SERPINE1KDM4E
SCHEMBL3970097 0.89 MEN1 (0.50) FABP4CHRM3FABP3CHRM1DHODH
SCHEMBL3910746 0.89 AKR1C4 (0.47) FABP4CHRM3FABP5SERPINE1CHRM1
SCHEMBL5100285 0.88 CHRM3 (0.56) FABP4CHRM3CNR1CHRM1CHRM2
SCHEMBL17796950 0.88 CHRM3 (0.52) FABP4CHRM3FABP5SERPINE1CNR1
SCHEMBL3913042 0.87 CHRM1 (0.56) CHRM3KDM4ENPSR1CHRM1
SCHEMBL17796921 0.87 FABP4 (0.48) FABP4CHRM3FABP5SERPINE1KDM4E
Hydrochloric Acid SCHEMBL5099086 0.86 CHRM1 (0.55) CHRM3KDM4ENPSR1CHRM1
SCHEMBL16438568 0.84 KMT2A (0.53) FABP4CHRM3KDM4ENPSR1CNR1
SCHEMBL10344931 0.84 PTGDR2 (0.58) FABP4CHRM3FABP5SERPINE1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3029026-B1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME DONG A ST CO LTD (KR) 2018-12-05 EP claimed
US-9828339-B2 Biphenyl derivatives and methods for preparing same DONG-A ST CO., LTD (KR) 2017-11-28 US claimed
US-20160176816-A1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME DONG-A ST CO., LTD (KR) 2016-06-23 US claimed
EP-3029026-A1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME Dong-A ST Co., Ltd. (KR) 2016-06-08 EP claimed
EP-3029026-B1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME DONG A ST CO LTD (KR) 2018-12-05 EP disclosed
EP-3029026-A1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME Dong-A ST Co., Ltd. (KR) 2016-06-08 EP disclosed
EP-3029026-A1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME Dong-A ST Co., Ltd. (KR) 2016-06-08 EP disclosed
WO-2015016511-A1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME 동아에스티 주식회사 (KR) 2015-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160176816-A1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME CHRM2, CHRM3, CHRM5 FABP4 2057/4885CHRM3 2/4885FABP5 1831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.